Literature DB >> 28566337

Age-Related Autonomous Aldosteronism.

Kazutaka Nanba1, Anand Vaidya1, Gordon H Williams1, Isabel Zheng1, Tobias Else1, William E Rainey2.   

Abstract

BACKGROUND: Both aging and inappropriate secretion of aldosterone increase the risk for developing cardiovascular disease; however, the influence of aging on aldosterone secretion and physiology is not well understood.
METHODS: The relationship between age and adrenal aldosterone synthase (CYP11B2) expression was evaluated in 127 normal adrenal glands from deceased kidney donors (age, 9 months to 68 years). Following immunohistochemistry, CYP11B2-expressing area and areas of abnormal foci of CYP11B2-expressing cells, called aldosterone-producing cell clusters, were analyzed. In a separate ancillary clinical study of 677 participants without primary aldosteronism, who were studied on both high and restricted sodium diets (age, 18-71 years), we used multivariable linear regression to assess the independent associations between age and renin-angiotensin-aldosterone system physiology.
RESULTS: In adrenal tissue, the total CYP11B2-expressing area was negatively correlated with age (r=-0.431, P<0.0001), whereas the total aldosterone-producing cell cluster area was positively correlated with age (r=0.390, P<0.0001). The integrated ratio of aldosterone-producing cell cluster to CYP11B2-expressing area was most strongly and positively correlated with age (r=0.587, P<0.0001). When participants in the clinical study were maintained on a high sodium balance, renin activity progressively declined with older age, whereas serum and urinary aldosterone did not significantly decline. Correspondingly, the aldosterone-to-renin ratio was positively and independently associated with older age (adjusted β=+5.54 ng/dL per ng/mL per hour per 10 years, P<0.001). In contrast, when participants were assessed under sodium-restricted conditions, physiological stimulation of aldosterone was blunted with older age (β=-4.6 ng/dL per 10 years, P<0.0001).
CONCLUSIONS: Aging is associated with a pattern of decreased normal zona glomerulosa CYP11B2 expression and increased aldosterone-producing cell cluster expression. This histopathologic finding parallels an age-related autonomous aldosteronism and abnormal aldosterone physiology that provides 1 potential explanation for age-related cardiovascular risk.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  aging; aldosterone; aldosterone-producing cell cluster; cytochrome P-450 CYP11B2; primary aldosteronism; renin

Mesh:

Substances:

Year:  2017        PMID: 28566337      PMCID: PMC5568806          DOI: 10.1161/CIRCULATIONAHA.117.028201

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  36 in total

1.  Effect on aging on plasma renin and aldosterone in normal man.

Authors:  P Weidmann; S De Myttenaere-Bursztein; M H Maxwell; J de Lima
Journal:  Kidney Int       Date:  1975-11       Impact factor: 10.612

2.  Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit?

Authors:  T Dekkers; M ter Meer; J W M Lenders; A R M Hermus; L Schultze Kool; J F Langenhuijsen; K Nishimoto; T Ogishima; K Mukai; E A B Azizan; B Tops; J Deinum; B Küsters
Journal:  J Clin Endocrinol Metab       Date:  2014-04-23       Impact factor: 5.958

3.  Reference values for aldosterone-renin ratios in normotensive individuals and effect of changes in dietary sodium consumption.

Authors:  Michiel N Kerstens; Anneke C Muller Kobold; Marcel Volmer; Jan Koerts; Wim J Sluiter; Robin P F Dullaart
Journal:  Clin Chem       Date:  2011-08-24       Impact factor: 8.327

Review 4.  Salt sensitivity: a review with a focus on non-Hispanic blacks and Hispanics.

Authors:  Safiya I Richardson; Barry I Freedman; David H Ellison; Carlos J Rodriguez
Journal:  J Am Soc Hypertens       Date:  2013-02-19

5.  Evidence of primary aldosteronism in a predominantly female cohort of normotensive individuals: a very high odds ratio for progression into arterial hypertension.

Authors:  Athina Markou; Theodora Pappa; Gregory Kaltsas; Aggeliki Gouli; Kostas Mitsakis; Panayiotis Tsounas; Anastasia Prevoli; Vaios Tsiavos; Labrini Papanastasiou; George Zografos; George P Chrousos; George P Piaditis
Journal:  J Clin Endocrinol Metab       Date:  2013-03-07       Impact factor: 5.958

Review 6.  The regulation of aldosterone synthase expression.

Authors:  Mary H Bassett; Perrin C White; William E Rainey
Journal:  Mol Cell Endocrinol       Date:  2004-03-31       Impact factor: 4.102

7.  Abnormal aldosterone physiology and cardiometabolic risk factors.

Authors:  Anand Vaidya; Patricia C Underwood; Paul N Hopkins; Xavier Jeunemaitre; Claudio Ferri; Gordon H Williams; Gail K Adler
Journal:  Hypertension       Date:  2013-02-11       Impact factor: 10.190

8.  Role of angiotensin II-induced rapid response genes in the regulation of enzymes needed for aldosterone synthesis.

Authors:  Edson F Nogueira; Yewei Xing; Claudia A V Morris; William E Rainey
Journal:  J Mol Endocrinol       Date:  2009-01-21       Impact factor: 5.098

9.  Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas.

Authors:  Silvia Monticone; Isabella Castellano; Karine Versace; Barbara Lucatello; Franco Veglio; Celso E Gomez-Sanchez; Tracy A Williams; Paolo Mulatero
Journal:  Mol Cell Endocrinol       Date:  2015-05-06       Impact factor: 4.102

10.  Continuum of Renin-Independent Aldosteronism in Normotension.

Authors:  Rene Baudrand; Francisco J Guarda; Carlos Fardella; Gregory Hundemer; Jenifer Brown; Gordon Williams; Anand Vaidya
Journal:  Hypertension       Date:  2017-03-13       Impact factor: 10.190

View more
  40 in total

Review 1.  The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment.

Authors:  Anand Vaidya; Paolo Mulatero; Rene Baudrand; Gail K Adler
Journal:  Endocr Rev       Date:  2018-12-01       Impact factor: 19.871

Review 2.  Steroid Profiling and Immunohistochemistry for Subtyping and Outcome Prediction in Primary Aldosteronism-a Review.

Authors:  Finn Holler; Daniel A Heinrich; Christian Adolf; Benjamin Lechner; Martin Bidlingmaier; Graeme Eisenhofer; Tracy Ann Williams; Martin Reincke
Journal:  Curr Hypertens Rep       Date:  2019-09-03       Impact factor: 5.369

3.  Expression of aldosterone synthase CYP11B2 was inversely correlated with longevity.

Authors:  Taiki Hayashi; Zhen Zhang; Ghaith Al-Eyd; Atsushi Sasaki; Masanori Yasuda; Masafumi Oyama; Celso E Gomez-Sanchez; Hirotaka Asakura; Tsugio Seki; Kuniaki Mukai; Koshiro Nishimoto
Journal:  J Steroid Biochem Mol Biol       Date:  2019-04-08       Impact factor: 4.292

Review 4.  Aldosterone-Producing Cell Clusters in Normal and Pathological States.

Authors:  Kei Omata; Scott A Tomlins; William E Rainey
Journal:  Horm Metab Res       Date:  2017-12-04       Impact factor: 2.936

Review 5.  Aging and Adrenal Aldosterone Production.

Authors:  Kazutaka Nanba; Anand Vaidya; William E Rainey
Journal:  Hypertension       Date:  2017-12-11       Impact factor: 10.190

Review 6.  Immunohistochemistry of the Human Adrenal CYP11B2 in Normal Individuals and in Patients with Primary Aldosteronism.

Authors:  Celso E Gomez-Sanchez; Elise P Gomez-Sanchez; Koshiro Nishimoto
Journal:  Horm Metab Res       Date:  2020-04-14       Impact factor: 2.936

Review 7.  Kidney and epigenetic mechanisms of salt-sensitive hypertension.

Authors:  Wakako Kawarazaki; Toshiro Fujita
Journal:  Nat Rev Nephrol       Date:  2021-02-24       Impact factor: 28.314

Review 8.  Proinflammatory Arterial Stiffness Syndrome: A Signature of Large Arterial Aging.

Authors:  Mingyi Wang; Robert E Monticone; Kimberly R McGraw
Journal:  J Vasc Res       Date:  2018-08-02       Impact factor: 1.934

Review 9.  Primary Aldosteronism: Practical Approach to Diagnosis and Management.

Authors:  James Brian Byrd; Adina F Turcu; Richard J Auchus
Journal:  Circulation       Date:  2018-08-21       Impact factor: 29.690

10.  Cellular and Genetic Causes of Idiopathic Hyperaldosteronism.

Authors:  Kei Omata; Fumitoshi Satoh; Ryo Morimoto; Sadayoshi Ito; Yuto Yamazaki; Yasuhiro Nakamura; Sharath K Anand; Zeng Guo; Michael Stowasser; Hironobu Sasano; Scott A Tomlins; William E Rainey
Journal:  Hypertension       Date:  2018-10       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.